Recent trends in antifungal agents and antifungal therapy / Amit Basak, Ranadhir Chakraborty, Santi M. Mandal, editors.
"Fungalinfections have taken a new spectrum due to the increased incidence ofmulti-drug resistant fungal pathogens. Freedom of choice for drugs to treatfungal infections is also narrow because of lesser probability of discovering drugsthat would bypass affecting human cells and target fungal ce...
I tiakina i:
Ētahi atu kaituhi: | , , |
---|---|
Hōputu: | iPukapuka |
Reo: | English |
I whakaputaina: |
[India] :
Springer,
[2016]
|
Ngā marau: | |
Urunga tuihono: | Springer eBooks |
MARC
LEADER | 00000czm a2200000Mi 4500 | ||
---|---|---|---|
005 | 20231012155524.0 | ||
006 | m o d | ||
007 | cr |n||||||||| | ||
008 | 160927s2016 ii ob 000 0 eng d | ||
011 | |a Z3950 Search: @or @attr 1=7 "9788132227809" @attr 1=7 "9788132227823" | ||
011 | |a Z3950 Record: 0 of 14 | ||
020 | |a 8132227808 |q Internet | ||
020 | |a 9788132227809 |q Internet | ||
020 | |a 8132227824 |q Internet | ||
020 | |a 9788132227823 |q Internet | ||
035 | |a (OCoLC)959274790 | ||
035 | |a (EDS)EDS11609718 | ||
037 | |a com.springer.onix.9788132227823 |b Springer Nature | ||
040 | |a YDX |b eng |e rda |c YDX |d N$T |d IDEBK |d EBLCP |d GW5XE |d OCLCQ |d NJR |d OCLCF |d UPM |d COO |d OCLCA |d IOG |d UAB |d OCLCO |d JG0 |d IAD |d JBG |d ICW |d ILO |d ICN |d ESU |d VT2 |d U3W |d REB |d CAUOI |d KSU |d AU@ |d WYU |d BRX |d UKMGB |d UKAHL |d ERF |d UKBTH |d LEATE |d LQU |d AJS |d Z5A | ||
050 | 4 | |a RS431.A62 | |
050 | 4 | |a QH301-705 | |
082 | 0 | 4 | |a 615.792 |2 23 |
082 | 0 | 4 | |a 570 |
245 | 0 | 0 | |a Recent trends in antifungal agents and antifungal therapy / |c Amit Basak, Ranadhir Chakraborty, Santi M. Mandal, editors. |
264 | 1 | |a [India] : |b Springer, |c [2016] | |
264 | 4 | |c ©2016 | |
300 | |a 1 online resource | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a text file | ||
504 | |a Includes bibliographical references. | ||
505 | 0 | 0 | |t Fungi Fights Fungi: Tip-off in Antifungal Chemotherapy / |r Santi M. Mandal, Anupam Roy, Debarati Paul, Suresh Korpole, Shanker Lal Shrivastava, Ranadhir Chakraborty et al. -- |t Essential Oil and Antifungal Therapy / |r Mohammad Moghaddam, Leila Mehdizadeh -- |t Antifungal Peptides with Potential Against Pathogenic Fungi / |r Camila G. Freitas, Octávio L. Franco -- |t Lipopeptides: Status and Strategies to Control Fungal Infection / |r Piyush Baindara, Suresh Korpole -- |t Plant-Derived Antifungal Agents: Past and Recent Developments / |r G. M. Vidyasagar -- |t Recent Advancements in Combinational Antifungal Therapy and Immunotherapy / |r Sudarshan Singh Rathore, Jayapradha Ramakrishnan, Thiagarajan Raman -- |t Nanocarriers of Antifungal Agents / |r Sevgi Güngör, M. Sedef Erdal -- |t Synthetic Compounds for Antifungal Chemotherapy / |r Rupa Pegu, Rohan Borah, Sanjay Pratihar -- |t Antifungal Therapy in Eye Infections: New Drugs, New Trends / |r Joveeta Joseph, Savitri Sharma -- |t Antifungal Susceptibility Testing of Dermatophytes / |r Indira Gadangi. |
520 | |a "Fungalinfections have taken a new spectrum due to the increased incidence ofmulti-drug resistant fungal pathogens. Freedom of choice for drugs to treatfungal infections is also narrow because of lesser probability of discovering drugsthat would bypass affecting human cells and target fungal cells producing fewerside effects in patients. An approach has gained prominence in research is tolook for bioactive antifungal compounds from natural to synthetic sources. Itis necessary to discover new classes of antifungals to control the recentemergence of multi-drug resistant fungal infections. This book proposed adetails top to bottom outline of antifungal compounds derived naturally orsynthetically. The details of their modifications or synthetic analogues havebeen described, helpful to understand the structure-activity relationship whichleads to new compound development in antifungal chemotherapy. Each chapterbegins with a comprehensive, top-bottom in-depth discussion of antifungalagents with updated bibliographic references. This compendium will serve as acompanion not only for Scientists, Researchers, and Professors, Medical Practitioners but also a valuable reference text for the university students. "--Publisher's website. | ||
588 | |a Machine converted from non-AACR2, ISBD-encoded source record. | ||
650 | 0 | |a Antifungal agents. |9 344477 | |
700 | 1 | |a Basak, Amit. |9 859317 | |
700 | 1 | |a Chakraborty, Ranadir. | |
700 | 1 | |a Mandal, Santi M. |9 859319 | |
776 | 0 | 8 | |i Print version: |t Recent trends in antifungal agents and antifungal therapy. |d [India] : Springer, ©2016 |z 8132227808 |z 9788132227809 |w (OCoLC)939532088 |
776 | 1 | 8 | |w (OCoLC)958984634 |w (OCoLC)959536707 |w (OCoLC)961890517 |w (OCoLC)962254148 |w (OCoLC)962725908 |w (OCoLC)964328880 |w (OCoLC)964543931 |w (OCoLC)964922808 |w (OCoLC)967623996 |w (OCoLC)988838666 |w (OCoLC)1005828934 |w (OCoLC)1011965368 |w (OCoLC)1048193074 |w (OCoLC)1058609740 |w (OCoLC)1066484386 |w (OCoLC)1097142034 |w (OCoLC)1112545885 |w (OCoLC)1112966455 |w (OCoLC)1113393029 |w (OCoLC)1117183301 |w (OCoLC)1122812628 |w (OCoLC)1127173000 |w (OCoLC)1136429942 |w (OCoLC)1136523940 |w (OCoLC)1159610792 |
856 | 4 | 0 | |u https://ezproxy.aut.ac.nz/login?url=https://link.springer.com/10.1007/978-81-322-2782-3 |z Springer eBooks |x TEMPORARY ERM URL |
942 | |c EB |n 0 | ||
999 | |c 1367142 |d 1367142 |